Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Mar;27(3):332–336. doi: 10.1128/aac.27.3.332

Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.

J N Krieger, C S Dickins, M F Rein
PMCID: PMC176271  PMID: 3873214

Abstract

The emergence of metronidazole-resistant Trichomonas vaginalis and questions about the safety of metronidazole are significant concerns in treatment of trichomoniasis. At 24 h, a microtiter assay was used to test antimicrobial susceptibility of 16 recent isolates; the MICs of metronidazole ranged from less than 0.06 to 25 micrograms/ml. Observable motility as an endpoint correlated imperfectly with survival as measured in pour plates. Quantitative pour plate cultures of six T. vaginalis isolates after timed exposures to antimicrobial drugs demonstrated exquisite sensitivity to metronidazole with minimal trichomonacidal concentrations of 0.025 to 0.100 micrograms/ml. Killing of some T. vaginalis isolates by clotrimazole and rosoxacin occurred only at concentrations of 100 micrograms/ml. Resistance to both rosoxacin and clotrimazole correlated with increasing resistance to metronidazole (P less than 0.01).

Full text

PDF
335

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaulieu B. B., Jr, McLafferty M. A., Koch R. L., Goldman P. Metronidazole metabolism in cultures of Entamoeba histolytica and Trichomonas vaginalis. Antimicrob Agents Chemother. 1981 Sep;20(3):410–414. doi: 10.1128/aac.20.3.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Catterall R. D. Trichomonal infections of the genital tract. Med Clin North Am. 1972 Sep;56(5):1203–1209. doi: 10.1016/s0025-7125(16)32345-8. [DOI] [PubMed] [Google Scholar]
  3. Cohen A. I., Rein M. F., Noble R. C. A comparison of rosoxacin with ampicillin and probenecid in the treatment of uncomplicated gonorrhea. Sex Transm Dis. 1984 Jan-Mar;11(1):24–27. doi: 10.1097/00007435-198401000-00005. [DOI] [PubMed] [Google Scholar]
  4. Edwards D. I., Thompson E. J., Tomusange J., Shanson D. Inactivation of metronidazole by aerobic organisms. J Antimicrob Chemother. 1979 May;5(3):315–316. doi: 10.1093/jac/5.3.315. [DOI] [PubMed] [Google Scholar]
  5. Hager W. D., Brown S. T., Kraus S. J., Kleris G. S., Perkins G. J., Henderson M. Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimens. JAMA. 1980 Sep 12;244(11):1219–1220. [PubMed] [Google Scholar]
  6. Koch-Weser J., Goldman P. Drug therapy: metronidazole. N Engl J Med. 1980 Nov 20;303(21):1212–1218. doi: 10.1056/NEJM198011203032106. [DOI] [PubMed] [Google Scholar]
  7. Kock R. L., Beaulieu B. B., Jr, Chrystal E. J., Goldman P. A metronidazole metabolite in human urine and its risk. Science. 1981 Jan 23;211(4480):398–400. doi: 10.1126/science.7221546. [DOI] [PubMed] [Google Scholar]
  8. Korner B., Jensen H. K. Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro. Br J Vener Dis. 1976 Dec;52(6):404–408. doi: 10.1136/sti.52.6.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Krieger J. N., Rein M. F. Zinc sensitivity of Trichomonas vaginalis: in vitro studies and clinical implications. J Infect Dis. 1982 Sep;146(3):341–345. doi: 10.1093/infdis/146.3.341. [DOI] [PubMed] [Google Scholar]
  10. Krieger J. N. Urologic aspects of trichomoniasis. Invest Urol. 1981 May;18(8):411–417. [PubMed] [Google Scholar]
  11. Legal H. P. The treatment of trichomonas and candida vaginitis with clotrimazole vaginal tablets. Postgrad Med J. 1974 Jul;50 (Suppl 1):81–83. [PubMed] [Google Scholar]
  12. Legator M. S., Connor T. H., Stoeckel M. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice. Science. 1975 Jun 13;188(4193):1118–1119. doi: 10.1126/science.766186. [DOI] [PubMed] [Google Scholar]
  13. Lindmark D. G., Müller M. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother. 1976 Sep;10(3):476–482. doi: 10.1128/aac.10.3.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lohmeyer H. Treatment of candidiasis and trichomoniasis of the female genital tract. Postgrad Med J. 1974 Jul;50 (Suppl 1):78–79. [PubMed] [Google Scholar]
  15. McFadzean J. A., Pugh I. M., Squires S. L., Whelan J. P. Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole. Br J Vener Dis. 1969 Jun;45(2):161–162. doi: 10.1136/sti.45.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Meingassner J. G., Havelec L., Mieth H. Studies on strain sensitivity of Trichomonas vaginalis to metronidazole. Br J Vener Dis. 1978 Apr;54(2):72–76. doi: 10.1136/sti.54.2.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meingassner J. G., Mieth H. Cross-resistance of Trichomonads to 5-nitroimidazole-derivatives. Experientia. 1976 Feb 15;32(2):183–184. doi: 10.1007/BF01937754. [DOI] [PubMed] [Google Scholar]
  18. Meingassner J. G., Mieth H., Czok R., Lindmark D. G., Müller M. Assay conditions and the demonstration of nitroimidazole resistance in Tritrichomonas foetus. Antimicrob Agents Chemother. 1978 Jan;13(1):1–3. doi: 10.1128/aac.13.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Meingassner J. G., Thurner J. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother. 1979 Feb;15(2):254–257. doi: 10.1128/aac.15.2.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ralph E. D., Darwish R., Austin T. W., Smith E. A., Pattison F. L. Susceptibility of Trichomonas vaginalis strains to metronidazole: response to treatment. Sex Transm Dis. 1983 Jul-Sep;10(3):119–122. doi: 10.1097/00007435-198307000-00003. [DOI] [PubMed] [Google Scholar]
  21. Rustia M., Shubik P. Induction of lung tumors and malignant lymphomas in mice by metronidazole. J Natl Cancer Inst. 1972 Mar;48(3):721–729. [PubMed] [Google Scholar]
  22. Smith R. F., Di Domenico A. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method. Sex Transm Dis. 1980 Jul-Sep;7(3):120–124. doi: 10.1097/00007435-198007000-00005. [DOI] [PubMed] [Google Scholar]
  23. Thurner J., Meingassner J. G. Isolation of Trichomonas vaginalis resistant to metronidazole. Lancet. 1978 Sep 30;2(8092 Pt 1):738–738. doi: 10.1016/s0140-6736(78)92739-3. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES